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Background: Even today, repair of the cranial defects still represents a significant challenge 
in neurosurgery and various options have been used for their reconstruction to date. but there 
are very few studies investigating the effects of exogenous administration of melatonin 
(MEL) as an agent that promotes bone regeneration. The goal of this study was to investigate 
the effects of functional pinealectomy (Px) and exogenous MEL administration on the bone 
repair properties and surrounding connective tissue alterations in a rat calvaria model. 
Materials and methods: The total of 30 adult female Wistar-Albino rats was randomly 
divided into three groups (n = 10): control (CO) group (12 h light/12 h dark exposure), 
functional Px group (24 h light exposure, light-induced functional Px), and Px+MEL group 
(light-induced Px plus MEL, 20 mg/kg/day for 12 weeks). Critical-sized burr-hole defects 
(diameter = 3.0 mm) were surgically created by a single operator in the calvarium of all rats, 
using an electric drill. Animals in Px+MEL group received MEL 20 mg/kg/day for 12 weeks. 
At the end of the study, bone healing and connective tissue alterations surrounding drilled 
defect area in the rat calvaria were determined in hematoxylin/eosin-stained and mallory azan 
slices applied in anti-bone sialoprotein (BSP). Image Pro Express 4.5 program was used for 
histomorphometric calculation of areas of new bone and fibrotic tissue. Normality control was 
performed by Shapiro Wilk test. Variance homogeneities were examined by Shapiro Wilk and 
Levene tests; Tukey HSD test was used as a post hoc method since there was no homogeneity 
problem. All hypothesis tests were performed at the 0.05 significance level. 
Results: Histological analysis showed that the bone repair process in the Px+MEL group was 
similar to that of the CO group, whereas the functional Px group showed a delay. 
Histomorphometrically, it was found that the Px group had the largest hole diameter and the 
most fibrotic scar area, although no binary statistical significance was found between the CO 
and Px+MEL groups (p=0.910). In terms of vascularization, it was observed that the most 
vascular structure was found in the Px+MEL group among the scar tissue and ossification 
areas, while the vascularization was the least in the Px group (p < 0.001). 
Conclusions: Our findings revealed that bone repair process was impaired in functional Px 
group, but exogenous MEL replacement was able to restore this response. Thus, it is 
concluded that utilization of MEL may improve the bone repair in calvarial defects. 
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INTRODUCTION 
Bone healing, also called bone turnover or restoration of the bone microarchitecture, 
after various acquired defects or congenital deformities of the cranium, such as traumatic 
injuries, congenital deformities, decompressive craniectomies, or bone flap loss due to 
infections still represents a significant challenge in neurosurgery. Although numerous studies 
have been conducted to develop biomaterials displaying osteoconductive and/or 
osteoinductive properties to date, utilization of autogenous bone for repair of the cranial 
defects seems to be the most appropriate option, possibly due to its biosafety and cost 
advantage [29]. However, risks of additional morbidity to the patient related to obtaining the 
graft and resorption of the autogenous bone grafts limit their utilization in the repair of the 
cranial defects. As a result, there is still no consensus on which agent to be used in 
cranioplasty is better in reconstruction of the cranial defects in humans. To improve the bone 
regeneration and quality of the bone, therefore, use of various agents such as topical or 
systemic application of growth factors, cytokines and melatonin (MEL) has attracted the 
attention of scientists [3-5, 7, 8, 9, 14, 16, 21, 22, 25, 26, 30, 33-37].  
In normal remodelling cycle of the bone, which is balanced between bone-forming 
osteoblasts and bone resorbing osteoclasts, the resporption phase is followed by bone 
formation phase, including osteoid formation and then mineralization [1, 2, 10]. In recent 
years, it has been reported that MEL can have a pivotal role in this process when age-related 
osteoporosis is manifested, possibly due to an imbalance in bone turnover related with 
decreased level of the circulating MEL hormone; thus MEL could act as an autacoid or a local 
growth factor for the bone cells [4, 6, 7, 30, 36]. Importantly, it has also been reported that the 
proliferation of osteoblasts and the expression of type I collagen and biochemical markers of 
bone turnover, including bone sialoprotein (BSP) are also promoted by MEL [7, 9, 17, 25, 26, 
35]. Despite promising results, however, very few studies have been conducted to investigate 
the effects of exogenous administration of MEL as an agent that promotes bone regeneration 
to date and there is still no consensus on which agent to be used in cranioplasty is better in 
reconstruction of the cranial defects in humans. 
In this experimental study, our main purpose was to investigate the effects of 
exogenous MEL administration on bone healing and connective tissue alterations surrounding 
the bone defect histopathologically after production of burr hole in the calvarium of the rats 
exposed to functional pinealectomy (Px). 
MATERIALS AND METHODS 
In this study, 30 adult 200 gr female Wistar-Albino rats were used. The experimental 
protocol was approved by the Ethical Committee of Aydın Adnan Menderes University 
(HADYEK 64583101/2014/063). Animals were housed in rat cages in standard conditions 
(24±2°C and 50±5% humidity), exposed to 12:12-h light/dark cycle, fed with standardized 
rodent chow and tap water ad libitum. 
The rats were divided into three groups, with 10 animals per group. The first group of 
animals formed the control group (CO), which was exposed to 12:12-h light/dark cycle. The 
second and third groups were exposed to 24-hour continuous light for 12 weeks in order to 
produce light-induced functional Px, as described in a previous study [23]. Next, all rats 
underwent ketamine/xylasine (50 and 5 mg/kg, respectively) anesthesia, and a burr hole 
(diameter=3.0 mm) was produced using using an electric drill (CLASS Mini Grinder sets, 
PRC) on the right side of the calvarium. Then the wound was closed (Fig. 1). The animals in 
the second and third groups were moved back to the continuous light-burning room; 
meanwhile exogenous MEL treatment (Px + MEL) was applied to only the third group. 
MEL (N-acetyl-5-methoxytryptamine, cat. no: M-5250, Sigma Chemical Co., St 
Louis, MO, USA) was first dissolved in pure ethanol and kept in -20°C. The second dilution 
of this stock was freshly prepared in saline to have 5% ethanol concentration [13]. In the third 
group, 20 mg/kg/day of MEL was given intraperitoneally as a single injection for 12 weeks. 
At the end of 12 weeks, all the rats decapitated under the ketamine/xylasine (50 
and 5 mg/kg, respectively) anesthesia. The calvarial area which underwent the burr hole 
operation was removed for further histological study. 
Histological examination of calvaria 
Following sacrification, calvaria were collected into 10% formalin solution for at 
least 24 h before placement in decalsification solution containing 10% formaldehyde and 
20% formic acid for 2 months, softening of the tissue was controlled by punch 
ingregularly. Tissues were embedded to block in blue-beaded paraffin solution after 
processing in alcohol and xylol series. 5 µm sections were obtained by Leica RM 2145 
microtome, transferred to water bath at 45oC and microwaved to ensure adhesion and to 
remove any paraffin remaining. Hematoxylin-eosin (H-E), Mallory Azan staining and 
anti-BSP (bs-4729R, Bioss, 1:100) were applied to the related calvarial area and the 
surgical specimens were evaluated at 10x-20x magnification using an Olympus C5050 
camera attached to Olympus BX51 light microscope. 
Histomorphometry 
For histomorphometric analysis, counting and measurements were made for hole 
diameter, fibrotic scar areas, ossification areas and number of vessels in the sections 
taken from calvaria samples from each subject in the experimental groups [15, 18, 42]. 
Measurement for new ossification areas and fibrotic scar areas was calculated in square 
micrometers (µm2) using Image Pro Express 4.5 (Media Cybernetics, Inc., Rockville, 
MD, USA program. 
Statistical analysis 
Data analysis was carried out in IBM SPSS (Statistical Package for Social Sciences) 
Statistics for Windows, Version 25.0. (IBM Corp. Released 2017, Armonk, NY) package 
program. Group comparisons were performed using one-way analysis of variance method. 
Normality control was performed by Shapiro Wilk test that obtained from estimated error. 
Since there was no problem of adaptation to normal distribution, the study continued with 
one-way analysis of variance. Variance homogeneities were examined by Levene test; Tukey 
HSD test was used as a post hoc method, since there was no homogeneity problem. All 





When the skin on the calvarium was dissected, drilled holes were detected on the bone 
and these closed holes were observed macroscopically (Fig. 1). It was found that the scar 
tissue in the Px+MEL samples were closer to normal when compared with the other two 
groups (Fig. 2). 
Microscopic examination 
 In the microscopic sections, the orientation of the hole in the bone was adjusted and 
serial sections were taken. These sections were stained in H-E and Mallory Azan in order to 
show the general structure and were applied in anti-BSP immunohistochemistry. 
Histologically, the holes were found in the sections. Importantly, it was found that these hole 
structures were filled with irregular dense connective tissue called fibrotic in both control 
group and Px group (Fig. 3). 
When the hole diameters were evaluated statistically, it was seen that the Px group 
had the largest hole diameter. No statistical significance was found in the comparison of 
the groups with each other (Fig. 4A). When evaluated in terms of fibrotic scar area, it 
was calculated that the most scar area was in the Px group, although no binary statistical 
significance was found between the CO and Px+MEL groups. Importantly, a statistical 
significance was found when comparing these two groups with the Px group (p < 0.001) 
(Fig. 4B). When evaluated in terms of ossification areas, it was observed that the most 
ossification was in the Px+MEL group, while the highest ossification was found in the Px 
group. However, there was no statistical significance between the groups (p = 0.306) 
(Fig. 4C). In terms of vascularization, it was observed that the most vascular structure 
was found in the Px+MEL group among the scar areas and ossification areas, while the 
vascularization was the least in the Px group. When the CO and Px groups were 
compared, a statistically significant reduction was observed (p < 0.001). In similar, there 
was also a statistical significance difference between Px and Px+MEL groups (p < 0.001) 
(Fig. 4D). 
When this connective tissue structure was examined at larger magnification, it was 
found that they contain fibroblast-like cells and type I collagen bundles. In Px group, 
however, new bone splices were found that they were localized to different sites located 
within the connective tissue, possibly formed by intramembranous ossification. More 
importantly, in Px+MEL group, it was noted that this connective tissue area was small 
and ossification developed in most of the structure. With this appearance, it was the 
experimental group, which was closest to the normal histological structure of the other 
groups. Mallory Azan staining showed that the type I collagen bundles were stained blue 
while the newly formed bone areas were red (Fig. 5). 
 
DISCUSSION 
This experimental study evidenced that MEL replacement is related to the 
improvement of bone healing, in contrast to functional Px group, possibly due to increased 
osteoblastic activity and modulation of connective tissue alterations surrounding the bone 
defect driven by exogenous MEL administration in adult rats. 
 Previous studies reported that matrix cellular proteins, such as BSP, also called 
SPARC or BM40, osteopontin, tenascin C, and thrombospondin-1 and 2, are the critical 
regulators of bone healing process [1, 10]. BSP is composed of mineralized tissues such as 
bone, dentin, cementum and calcified cartilage. It binds to hydroxyapatite crystals and an 
integral part of the mineral matrix in bone tissue. Now, it is known to be an important 
component of the extracellular matrix of bone and forms all non-collagen proteins found in 
bone and cementum. In our study, the cell characterization of the osteoblast lineage was via 
immunostaining for BSP. The CO and Px+MEL groups are similar in terms of BSP, both 
groups have a high level of immune reaction. A lower degree of immunoreaction was detected 
in the Px group. 
Several studies documented that MEL has been linked to osteoblastic differentiation 
and bone metabolism [4, 6, 30, 36]. In a previous study, Witt et al. (2006) demonstrated that 
MEL influences bone cell precursors in rat bone marrow which has high concentrations of 
MEL [41]. Koyama, et al. (2002) showed that the administration of pharmacological doses of 
MEL during the growth of young rats increased the bone mass through the inhibition of bone 
resorption [14]. To date, however, the role of MEL replacement has not yet been widely 
evaluated in adult animals with lower production of endogenous MEL, as did in our 
functional Px group. In this study, we would like to investigate its role on bone healing in our 
study; therefore we applied a functional Px rat model to evaluate the effect of exogenous 
MEL administration histopathologically [23]. 
Experimental studies revealed that action of exogenous and endogenous MEL upon 
bone tissue is due to an increased osteoblastic activity, a decreased osteoclastic activity, and 
an increased osteoclastogenesis inhibitory factor, also known as osteoprotegerin, thus 
increasing its mass [14, 19, 33, 40]. In addition to its stimulating effect on bone metabolism 
and production of type I collagen, inhibitory effect on proteasomes has also been suggested 
[14, 19, 33, 40]. Thus, promotion of bone healing by MEL could be related with one or more 
of the following possible mechanisms: the promotion of the osteoblast differentiation and/or 
activity, an increased expression of the osteoprotegerin by osteoblasts, resulting with a 
decreased differentiation of osteoclasts, and increased scavenging of free radicals which were 
generated by osteoclasts [31]. Further, and more specifically, it has been speculated that MEL 
interferes with bone healing in several ways: through modulation of oxidative stres [27, 28, 
32], collagen fibril formation [19], differentiation of osteoblasts via PDGF/AKT signaling 
pathway [9, 25, 26, 35, 43], or activity of osteoblasts and osteoclasts via MEL-MT2 receptor 
pathway [9, 34, 41] or RANK/NF-κB signaling pathway [14, 26] or Wnt/β-catenin signaling 
pathway [40, 25, 16, 40]. Moreover, MEL has also been found to stimulate gene expression of 
BSP and other bone marker proteins including alkaline phosphate, secreted protein, 
osteocalcin and osteopontin [30]. 
Despite accumulating evidence about the effects of MEL upon regeneration of the 
bone tissue during the last decades, its use for cranial defects has received little attention and 
to date, healing of the bone after application of MEL has been evaluated in few experimental 
animal studies using model of calvaria [9, 25, 26, 35]. In addition to stimulatory action of 
MEL related with bone formation, however, possible effects of MEL upon the connective 
tissue surrounding the cranial defect have been also investigated for the first time in this 
study. Based on our findings, it is evident that the ossification process is accelerated by the 
effect of exogenous MEL, while the absence of endogenous MEL also negatively affects 
ossification. 
On the other hand, it has been reported that a lower production of MEL, by some 
genetic modifications (pineal MEL deficient mice, C57BL/6 and Swiss strains) [12, 34], or 
various Px techniques (surgical or functional) [21, 22, 24, 37-39] results in alterations in 
structure, density and mechanical strength of the bone in animals including mice, rat, rabbit, 
chicken, sheep, and fish [9, 34]. To the best of our knowledge, however, no study was 
performed to evaluate the healing in endogenous MEL deficiency and exogenous MEL 
administration, when added to biomaterials or implants [3-6, 36]. Thus, the process of how 
the absence of endogenous MEL interferes with the bone healing is unclear. Considering this, 
the purpose of this study was to evaluate the cellular changes that occur in the bone of rats 
undergoing Px that received or did not receive daily exogenous MEL replacement as a 
possible therapy for conditions characterized by a decrease in the secretion of this hormone by 
the pineal gland. 
In a previous in vitro study, it has been suggested that exogenous MEL administration 
has positive effects on both angiogenesis and wound healing [19]. In a recently published 
paper, Filipowska et al. (2017) also suggested the role of production of vascular endothelial 
growth factor (VEGF) by either hypertrophic chondrocytes or differentiating mesenchymal 
cells in bone development and regeneration [11]. In fact, our findings confirm that beneficial 
effects of MEL on blood vessel invasion for initiation of bone tissue formation, possibly as a 
result of increased VEGF production by MEL. 
Taken together our findings provide an evidence that the absence of MEL delays 
repair and exogenous MEL replacement regulates this alteration, which would emphasize the 
role of this neurohormone in bone remodeling, especially in conditions in which a decrease 
occurs in the circadian release capacity of this hormone by the pineal gland, as did in various 
clinical disease conditions. Undoubtedly, further understanding of pathological changes in the 
bone tissue and their reversion is critical for the success of MEL replacement treatment. Two 
limitations of our study that created an in vivo rat calvaria model are as follows: absence of 
any analysis for inorganic material content of bone tissue and difference of drilled defects 
from those in humans in terms of bone remodelling. Also, lack of any imaging study 
illustrating bone healing and angiogenesis is another limitation of the study. Future studies 
including imaging are needed for beter understanding of modulation of osteoblast and 
osteoclast function and mineralization with MEL in cases of bone defect that simulates the 
sitution in human. 
 
CONCLUSIONS 
Based on the results of this study, we may notice an interaction in cellular responses 
and protein activity in the absence of MEL, suggesting that when there is a delay in the 
production of proteins that stimulate bone formation, ossification because of hormone 
administration increases vascularization and may result in less scar tissue formation. The 
MEL replacement, in most parameters evaluated in this study, showed a behavior very close 
to that of the CO group. Therefore, the absence of the pineal gland impairs the bone repair 
process during osseointegration, however the daily exogenous MEL replacement was able to 
partially restore this response. However, the authors believe that further studies should 
confirm this information in future. 
Acknowledgements 
The authors thank to Research Foundation of Aydın Adnan Menderes University 
(ADU-TPF- 15019) for funding of this research. We also thank the anonymous reviewers of 
the journal Folia Morphologica for their constructive comments and help with the manuscript. 
Author’ contributions as follows: HKB, MT, BD, and EOC led the project, performed the 
surgical procedures and drafted the manuscript. HKB, MT, YU, and CS carried out the 
histology, histomorphometry and analysis of markers of bone metabolism. YU and EOC 
performed the statistical analysis and helped to draft the manuscript. HKB, MT, and EOC 
conceived of the study, and participated in its design and coordination and helped to draft the 
manuscript. All authors read and approved the final manuscript and they declare that they 
have no conflict of interests. 
 
REFERENCES 
1. Alford AI, Hankenson KD. Matricellular proteins: extracellular modulators of bone development, 
remodeling, and regeneration. Bone 2006;38:749-757. 
2. Bilezikian JP, Raisz LG, Rodan GA. Principles of bone biology. 2nd. San Diego: Academic Press; 2002. 
1696. 
3. Calvo-Guirado JL, Gómez-Moreno G, Barone A, Cutando A, Alcaraz-Baños M, Chiva F, et al. Melatonin 
plus porcine bone on discrete calcium deposit implant surface stimulates osteointegration in dental 
implants. J Pineal Res 2009; 47:164-172. 
4. Calvo-Guirado JL, Gómez-Moreno G, López-Marí L, Guardia J, Marínez-González JM, Barone A, et al. 
Actions of melatonin mixed with collagenized porcine bone versus porcine bone only on osteointegration 
of dental implants. J Pineal Res 2010; 48:194-203. 
5. Calvo-Guirado JL, Gómez-Moreno G, Maté-Sánchez JE, López-Marí L, Delgado-Ruiz R, Romanos GE. 
New bone formation in bone defects after melatonin and porcine bone grafts: experimental study in rabbits. 
Clin Oral Implants Res 2015; 26:399-406. 
6. Calvo-Guirado JL, Ramírez-Fernández MP, Gómez-Moreno G, Maté-Sánchez JE, Delgado-Ruiz R, 
Guardia J, López-Marí L, Barone A, Ortiz-Ruiz AJ, Martínez-González JM, Bravo LA. Melatonin 
stimulates the growth of new bone around implants in the tibia of rabbits. J Pineal Res 2010;49:356-63. 
7. Cardinali DP, Ladizesky MG, Boggio V, Cutrera RA, Mautalen C. Melatonin effects on bone: experimental 
facts and clinical perspectives. J Pineal Res 2003; 34:81-87. 
8. Chaves LH, Giovanini AF, Zielak JC, Scariot R, Gonzaga CC, Storrer CLM, Khajotia SS, Florez FLE, 
Deliberador TM. Growth hormone effects on healing efficacy, bone resorption and renal morphology of 
rats: histological and histometric study in rat calvaria. Heliyon 2020;6: e05226. 
9. Clafshenkel WP, Rutkowski JL, Palchesko RN, Romeo JD, McGowan KA, Gawalt ES, Witt-Enderby PA. 
A novel calcium aluminate-melatonin scaffold enhances bone regeneration within a calvarial defect. J 
Pineal Res 2012; 53:206-218. 
10. Delany AM, Hankenson KD. Thrombospondin-2 and SPARC/osteonectin are critical regulators of bone 
remodeling. J Cell Commun Signal 2009; 3:227-238. 
11. Filipowska J, Tomaszewski KA, Niedźwiedzki Ł, Walocha JA, Niedźwiedzki T. The role of vasculature in 
bone development, regeneration and proper systemic functioning. Angiogenesis 2017;20:291-302. 
12. Gómez-Corvera A, Cerrillo I, Molinero P, Naranjo MC, Lardone PJ, Sanchez-Hidalgo M, Carrascosa-
Salmoral MP, Medrano-Campillo P, Guerrero JM, Rubio A. Evidence of immune system melatonin 
production by two pineal melatonin deficient mice, C57BL/6 and Swiss strains. J Pineal Res 2009; 47:15-
22. 
13. Kerem H, Akdemir O, Ates U, Uyanikgil Y, Sezer ED, Bilkay U, Turgut M, Sozmen E, Songur E. The 
effect of melatonin on a dorsal skin flap model. J Invest Surg 2014; 27:57-64. 
14. Koyama H, Nakade O, Takada Y, Kaku T, Lau KH. Melatonin at pharmacologic doses increases bone mass 
by suppressing resorption through down-regulation of the RANKL-mediated osteoclast formation and 
activation. J Bone Miner Res 2002; 17:1219-1229. 
15. Li J, Jin L, Wang M, Zhu S, Xu S. Repair of rat cranial bone defect by using bone morphogenetic protein-
2-related peptide combined with microspheres composed of polylactic acid/polyglycolic acid copolymer 
and chitosan. Biomed Mater 2015;10:045004.  
16. Li X, Li Z, Wang J, Li Z, Cui H, Dai G, Chen S, Zhang M, Zheng Z, Zhan Z, Liu H. Wnt4 signaling 
mediates protective effects of melatonin on new bone formation in an inflammatory environment. FASEB J 
2019; 33:10126-10139. 
17. Liu J, Huang F, He HW. Melatonin effects on hard tissues: Bone and tooth. Int J Mol Sci 2013; 14:10063-
10074. 
18. Liu W, Kang N, Seriwatanachai D, Dong Y, Zhou L, Lin Y, Ye L, Liang X, Yuan Q. Chronic kidney 
disease impairs bone defect healing in rats. Sci Rep 2016;6:23041. 
19. Nakade O, Koyama H, Ariji H, Yajima A, Kaku T. Melatonin stimulates proliferation and type I collagen 
synthesis in human bone cells in vitro. J Pineal Res 1999; 27:106-110. 
20. Ohlsson C, Bengtsson BA, Isaksson OG, Andreassen TT, Slootweg MC. Growth hormone and bone. 
Endocr Rev 1998; 19:55-79. 
21. Ostrowska Z, Kos-Kudla B, Marek B, Kajdaniuk D, Staszewicz P, Szapska B, Strzelczyk J. The influence 
of pinealectomy and melatonin administration on the dynamic pattern of biochemical markers of bone 
metabolism in experimental osteoporosis in the rat. Neuro Endocrinol Lett 2002;23 Suppl 1:104-109. 
22. Ostrowska Z, Kos-Kudla B, Nowak M, Swietochowska E, Marek B, Gorski J, Kajdaniuk D, Wolkowska K. 
The relationship between bone metabolism, melatonin and other hormones in sham-operated and 
pinealectomized rats. Endocr Regul 2003; 37:211-224. 
23. Ozkaya MS, Gundogdu A, Seyran M, Hindistan IE, Pamuk O, Ozkaya YG. Effect of exogenous melatonin 
administration on pain threshold in exercise trained rats under light-induced functional pinealectomy. Biol 
Rhythm Res 2014; 45:849-859. 
24. Pawlicki B, Henry BM, Tomaszewski KA, Gajda M, Brzozowska I, Walocha JA, Skowron-Cendrzak A. 
Neonatal pinealectomy in rats - a simple micro-suction technique. Folia Med Cracov 2017;57:39-46. 
25. Ping Z, Hu X, Wang L, Shi J, Tao Y, Wu X, Hou Z, Guo X, Zhang W, Yang H, Xu Y, Wang Z, Geng D. 
Melatonin attenuates titanium particle-induced osteolysis via activation of Wnt/β-catenin signaling 
pathway. Acta Biomater 2017; 51:513-525. 
26. Ping Z, Wang Z, Shi J, Wang L, Guo X, Zhou W, Hu X, Wu X, Liu Y, Zhang W, Yang H, Xu Y, Gu Y, 
Geng D. Inhibitory effects of melatonin on titanium particle-induced inflammatory bone resorption and 
osteoclastogenesis via suppression of NF-κB signaling. Acta Biomater 2017; 62:362-371. 
27. Ramírez-Fernández MP, Calvo-Guirado JL, de-Val JE, Delgado-Ruiz RA, Negri B, Pardo-Zamora G, et al. 
Melatonin promotes angiogenesis during repair of bone defects: a radiological and histomorphometric 
study in rabbit tibiae. Clin Oral Investig 2013; 17:147-158. 
28. Reiter RJ, Calvo JR, Karbownik M, Qi W, Tan DX. Melatonin and its relation to the immune system and 
inflammation. Ann N Y Acad Sci 2000; 917:376-386. 
29. Rogers GF, Greene AK. Autogenous bone graft: basic science and clinical implications. J Craniofac Surg 
2012; 23:323-327. 
30. Roth JA, Kim BG, Lin WL, Cho MI. Melatonin promotes osteoblast differentiation and bone formation. J 
Biol Chem 1999; 274:22041-22047. 
31. Sánchez-Barceló EJ, Mediavilla MD, Tan DX, Reiter RJ. Scientific basis for the potential use of melatonin 
in bone diseases: osteoporosis and adolescent idiopathic scoliosis. J Osteoporos. 2010 Jun 1;2010:830231. 
32. Seema R, Chandana H. Melatonin ameliorates oxidative stress and induces cellular proliferation of 
lymphoid tissues of a tropical rodent, Funambulus pennanti, during reproductively active phase. 
Protoplasma 2013;250:21-32. 
33. Sethi S, Radio NM, Kotlarczyk MP, Chen CT, Wei YH, Jockers R, et al. Determination of the minimal 
melatonin exposure required to induce osteoblast differentiation from human mesenchymal stem cells and 
these effects on downstream signaling pathways. J Pineal Res 2010; 49:222-238. 
34. Sharan K, Lewis K, Furukawa T, Yadav VK. Regulation of bone mass through pineal-derived melatonin-
MT2 receptor pathway. J Pineal Res 2017; 63:e12423. 
35. Shino H, Hasuike A, Arai Y, Honda M, Isokawa K, Sato S. Melatonin enhances vertical bone augmentation 
in rat calvaria secluded spaces. Med Oral Patol Oral Cir Bucal 2016; 21:e122-e126. 
36. Tresguerres IF, Tamimi F, Eimar H, Barralet JE, Prieto S, Torres J, et al. Melatonin dietary supplement as 
an anti-aging therapy for age-related bone loss. Rejuvenation Res 2014; 17:341-346. 
37. Turgut M, Kaplan S, Turgut AT, Aslan H, Güvenç T, Cullu E, Erdogan S. Morphological, stereological and 
radiological changes in pinealectomized chicken cervical vertebrae. J Pineal Res 2005; 39:392-399. 
38. Turgut M, Yenisey C, Bozkurt M, Ergin FA, Biçakçi T. Analysis of zinc and magnesium levels in 
pinealectomized chicks: roles on development of spinal deformity? Biol Trace Elem Res 2006; 113:67-75. 
39. Turgut M, Yenisey C, Uysal A, Bozkurt M, Yurtseven ME. The effects of pineal gland transplantation on 
the production of spinal deformity and serum melatonin level following pinealectomy in the chicken. Eur 
Spine J 2003; 12:487-494. 
40. Vriend J, Reiter RJ. Melatonin, bone regulation and the ubiquitin-proteasome connection: A review. Life 
Sci 2016; 145:152-160. 
41. Witt-Enderby PA, Radio NM, Doctor JS, Davis VL. Therapeutic treatments potentially mediated by 
melatonin receptors: potential clinical uses in the prevention of osteoporosis, cancer and as an adjuvant 
therapy. J Pineal Res 2006; 41:297-305. 
42. Zhang L, Chang M, Beck CA, Schwarz EM, Boyce BF. Analysis of new bone, cartilage, and fibrosis tissue 
in healing murine allografts using whole slide imaging and a new automated histomorphometric algorithm. 
Bone Res 2016;4:15037. 
43. Zhu G, Ma B, Dong P, Shang J, Gu X, Zi Y. Melatonin promotes osteoblastic differentiation and regulates 
PDGF/AKT signaling pathway. Cell Biol Int 2020; 44:402-411. 
 
 
Figure 1. The process of establishing the animal model of bone defect as burr hole on the 
right side of the rat calvarium using a drill with 3 mm in diameter. 
Figure 2. Demonstration of the experimentally produced bone lesions in all rat groups; A. 
Control (CO) group; B. Pinealectomy (Px) group; C. Px+melatonin (MEL) group. 
Figure 3. Microscopic evaluation of all groups; A. Control (CO) group; B. Pinealectomy 
(Px) group; C. Px+ melatonin (MEL) group. 
Figure 4. Statistical evaluation graph of histomorphometric analysis. Graphical representation 
of hole diameter (A), fibrotic scar area (B), ossification area (C) and number of vessels (D) in 
all groups. 
Figure 5. Microscopic evaluation of all groups; A. Control (CO) group; B. Pinealectomy (Px) 
group; C. Px+ melatonin (MEL) group. 





